Insiders who reported open-market trades in the last 12 months at the companies George A. Samuel III files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Brian M. Culley - $24K in LCTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
George A. Samuel III is a corporate insider, tracked as General Counsel and Secretary of Lineage Cell Therapeutics, Inc. (LCTX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did George A. Samuel III last file a Form 4?
The most recent primary Form 4 on record is dated 7 March 2026, one of 4 filings going back to 2024.
Has George A. Samuel III been buying or selling stock?
Recorded transactions: 1 open-market purchase ($9K) and 0 open-market sales across all tracked filings.
George A. Samuel III is General Counsel and Secretary of Lineage Cell Therapeutics, Inc. (LCTX). 4 SEC Form 4 filings on record going back to 2024, most recently on 7 March 2026. Most recent open-market trade: bought $9K of LCTX on 26 November 2024. Lifetime open-market purchases: $9K.
Recent transactions
5
The latest 5 SEC Form 4 transactions reported by George A. Samuel III.
InsiderAlpha's records for George A. Samuel III go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. The typical open-market purchase is $9K (1 buy totaling $9K). The largest single buy on record is $9K of LCTX in 2024. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
